Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-090993
Filing Date
2025-06-27
Accepted
2025-06-27 17:00:08
Documents
1
Period of Report
2025-06-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 13707
  Complete submission text file 0000950170-25-090993.txt   15500
Mailing Address 888 SEVENTH AVENUE 43RD FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 43RD FLOOR NEW YORK NY 10106 212-705-8800
QVT Financial LP (Reporting) CIK: 0001290162 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 251087434

Mailing Address 7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM United Kingdom SW1H 0DB
Business Address 7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM United Kingdom SW1H 0DB 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)